Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
c-myc mRNA is the messenger RNA that encodes the MYC protein, a transcription factor involved in controlling cell growth, proliferation, differentiation, and apoptosis[7][3][5]. Overexpression or dysregulation of c-myc mRNA leads to increased MYC protein production, promoting uncontrolled cell proliferation and cancer development—most notably observed in Burkitt lymphoma and other aggressive cancers[3][7]. Because direct targeting of the MYC protein remains challenging, c-myc mRNA is being studied as a potential therapeutic target, with strategies including antisense oligonucleotides or small interfering RNAs designed to degrade or block the translation of this mRNA transcript[7]. Elevated c-myc mRNA serves as a potential biomarker for the diagnosis, prognosis, and therapeutic stratification of certain cancers, though any therapy modulating its levels must balance anti-tumor efficacy with the risk of disrupting MYC’s physiological functions in normal tissues[6][7][5].
Antisense oligonucleotides or RNA interference: Degradation or inhibition of c-myc mRNA, reducing MYC protein synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on c-myc mRNA.